logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5209.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5209.produseast1
Showing 1 - 18 of 18 Items
Showing 1 - 18 of 18 Items
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Journal Article
|
Research

Feasibility, drug safety, and effectiveness of etiological treatment programs for Chagas disease in Honduras, Guatemala, and Bolivia: 10-year experience of Médecins Sans Frontières

Yun O, Lima MA, Ellman T, Chambi W, Castillo S,  et al.
2009-07-07 • PLOS Neglected Tropical Diseases
2009-07-07 • PLOS Neglected Tropical Diseases
BACKGROUND:
Chagas disease (American trypanosomiasis) is a zoonotic or anthropozoonotic disease caused by the parasite Trypanosoma cruzi. Predominantly affecting populations in poor...
Journal Article
|
Research

Decreased peripheral health service utilisation during an outbreak of Marburg haemorrhagic fever, Uíge, Angola, 2005

Roddy P, Marchiol A, Jeffs B, Palma PP, Bernal O,  et al.
2008-10-04 • Transactions of the Royal Society of Tropical Medicine and Hygiene
2008-10-04 • Transactions of the Royal Society of Tropical Medicine and Hygiene
In 2005, a Marburg haemorrhagic fever (MHF) outbreak occurred in Uíge province, Angola, which had its epicentre in Uíge municipality. Concurrently, a health facility located a considerab...
Journal Article
|
Research

The use of a mobile laboratory unit in support of patient management and epidemiological surveillance during the 2005 Marburg outbreak in Angola

Grolla A, Jones SM, Fernando L, Strong JE, Stroher U,  et al.
2011-05-24 • PLOS Neglected Tropical Diseases
2011-05-24 • PLOS Neglected Tropical Diseases
Background: Marburg virus (MARV), a zoonotic pathogen causing severe hemorrhagic fever in man, has emerged in Angola resulting in the largest outbreak of Marburg hemorrhagic fever (MHF) ...
Journal Article
|
Research

The Medecins Sans Frontieres intervention in the Marburg hemorrhagic fever epidemic, Uige, Angola, 2005. II. lessons learned in the community

Roddy P, Weatherill D, Jeffs B, Abaakouk Z, Dorion C,  et al.
2007-11-15 • Journal of Infectious Diseases
2007-11-15 • Journal of Infectious Diseases
From 27 March 2005 onwards, the independent humanitarian medical aid agency Medecins Sans Frontieres, together with the World Health Organization, the Angolan Ministry of Health, and oth...
Journal Article
|
Research

Clinical Manifestations and Case Management of Ebola Haemorrhagic Fever caused by a newly identified virus strain, Bundibugyo, Uganda, 2007-2008

Roddy P, Howard N, Van Kerkhove MD, Lutwama J, Wamala JF,  et al.
2012-12-28 • PLOS One
2012-12-28 • PLOS One
A confirmed Ebola haemorrhagic fever (EHF) outbreak in Bundibugyo, Uganda, November 2007-February 2008, was caused by a putative new species (Bundibugyo ebolavirus). It included 93 putat...
Journal Article
|
Research

Sentinel site community surveillance of mortality and nutritional status in southwestern Central African Republic, 2010

Caleo GNC, Sy AP, Balandine S, Polonsky JA, Palma PP,  et al.
2012-09-04 • Population Health Metrics
2012-09-04 • Population Health Metrics
During 2010, a community-based, sentinel site prospective surveillance system measured mortality, acute malnutrition prevalence, and the coverage of a Médecins Sans Frontières (MSF) inte...
Protocol
|
Research Protocol

A multi-center, open-label trial to compare the efficacy and pharmacokinetics of Artemether-Lumefantrine in children with severe acute malnutrition versus children without severe acute malnutrition: study protocol for the MAL-NUT study

Denoeud-Ndam L, Dicko A, Baudin E, Guindo O, Grandesso F,  et al.
2015-06-12 • BMC Infectious Diseases
2015-06-12 • BMC Infectious Diseases
Malnutrition and malaria frequently coexist in sub-Saharan African countries. Studies on efficacy of antimalarial treatments usually follow the WHO standardized protocol in which severel...
Journal Article
|
Research

Low castes have poor access to visceral leishmaniasis treatment in Bihar, India

Pascual Martinez F, Picado A, Roddy P, Palma PP
2012-03-05 • Tropical Medicine and International Health
2012-03-05 • Tropical Medicine and International Health
Objectives  Bihar, the poorest state in India, concentrates most of the visceral leishmaniasis (VL) cases in the country. A large proportion of the poor rural communities where VL is end...
Journal Article
|
Research

Treatment and seroconversion in a cohort of children suffering from recent chronic Chagas infection in Yoro, Honduras

Escriba JM, Ponce E, Romero Ade D, Albajar Viñas P, Marchiol A,  et al.
2009-11-01 • Memorias do Instituto Oswaldo Cruz
2009-11-01 • Memorias do Instituto Oswaldo Cruz
Between 1999-2002, Médécins Sans Frontières-Spain implemented a project seeking to determine the efficacy and safety of benznidazole in the treatment of recent chronic Chagas disease in ...
Journal Article
|
Review

Filovirus hemorrhagic fever outbreak case management: a review of current and future treatment options

Roddy P, Colebunders R, Jeffs B, Palma PP, Van Herp M,  et al.
2011-11-01 • Journal of Infectious Diseases
2011-11-01 • Journal of Infectious Diseases
Testing an innovative therapy for filovirus hemorrhagic fever (FHF) in an outbreak setting may be years away. Moreover, beyond anecdotal evidence, little is known about best practice for...
Journal Article
|
Research

Cholera epidemic in Guinea-Bissau (2008): the importance of "place"

Luquero FJ, Na Banga C, Remartinez D, Palma PP, Baron E,  et al.
2011-05-04 • PLOS One
2011-05-04 • PLOS One
BACKGROUND
As resources are limited when responding to cholera outbreaks, knowledge about where to orient interventions is crucial. We describe the cholera epidemic affecting Guinea-...
Journal Article
|
Research

Evaluation of Clinical and Immunological Markers for predicting Virological Failure in a HIV/AIDS treatment cohort in Busia, Kenya

Ferreyra C, Yun O, Eisenberg N, Alonso E, Khamadi AS,  et al.
2012-11-21 • PLOS One
2012-11-21 • PLOS One
In resource-limited settings where viral load (VL) monitoring is scarce or unavailable, clinicians must use immunological and clinical criteria to define HIV virological treatment failur...
Journal Article
|
Research

Frequency of sexually transmitted infections and related factors in Pweto, Democratic Republic of Congo, 2004

Luque Fernández MA, Bauernfeind A, Palma PP, Ruiz Pérez I
2008-07-08 • Gaceta sanitaria / S.E.S.P.A.S
2008-07-08 • Gaceta sanitaria / S.E.S.P.A.S
OBJECTIVES
To estimate the prevalence of genital ulcer and urethral discharge in Pweto, Democratic Republic of Congo, and to analyze the association between the estimated prevalence ...
Journal Article
|
Research

Effectiveness of a PMTCT programme in rural Western Kenya

Azcoaga-Lorenzo A, Ferreyra C, Alvarez A, Palma PP, Velilla E,  et al.
2011-02-22 • AIDS Care
2011-02-22 • AIDS Care
We assess the coverage of a Prevention of Mother-to-child Transmission (PMTCT) programme in Busia (Kenya) from 1 January 2006 to 31 December 2008 and estimate the risk of transmission of...
Journal Article
|
Research

Urban Cholera transmission hotspots and their implications for Reactive Vaccination: evidence from Bissau city, Guinea Bissau

Azman AS, Luquero FJ, Rodrigues A, Palma PP, Grais RF,  et al.
2012-11-08 • PLOS Neglected Tropical Diseases
2012-11-08 • PLOS Neglected Tropical Diseases
Use of cholera vaccines in response to epidemics (reactive vaccination) may provide an effective supplement to traditional control measures. In Haiti, reactive vaccination was considered...
Journal Article
|
Research

Natural history of a visceral leishmaniasis outbreak in highland Ethiopia

Herrero M, Orfanos G, Argaw D, Mulugeta A, Aparicio P,  et al.
2009-09-01 • American Journal of Tropical Medicine and Hygiene
2009-09-01 • American Journal of Tropical Medicine and Hygiene
In May 2005, visceral leishmaniasis (VL) was recognized for the first time in Libo Kemken, Ethiopia, a highland region where only few cases had been reported before. We analyzed records ...
Journal Article
|
Research

Liposomal amphotericin B for visceral leishmaniasis in human immunodeficiency virus-coinfected patients: 2-year treatment outcomes in Bihar, India

Sinha PK, van Griensven J, Pandey K, Kumar N, Verma N,  et al.
2011-10-01 • Clinical Infectious Diseases
2011-10-01 • Clinical Infectious Diseases
Reports on treatment outcomes of visceral leishmaniasis (VL)-human immunodeficiency virus (HIV) coinfection in India are lacking. To our knowledge, none have studied the efficacy of lipo...
Journal Article
|
Research

Effectiveness and safety of liposomal amphotericin B for visceral leishmaniasis under routine program conditions in Bihar, India

Sinha PK, Roddy P, Palma PP, Kociejowski A, Lima MA,  et al.
2010-08-01 • American Journal of Tropical Medicine and Hygiene
2010-08-01 • American Journal of Tropical Medicine and Hygiene
We evaluated, through the prospective monitoring of 251 patients at Sadar Hospital in Bihar, India, the effectiveness and safety of 20 mg/kg body weight of liposomal amphotericin B for t...